Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Chang

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2012
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trialJyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, et al.
The Lancet. Oncology|December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trialSung Won Choi, Thomas Braun, Lawrence Chang, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2012
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trialJyh-Ming Liou, Chieh-Chang Chen, Chi-Yang Chang, et al.
The Lancet. Oncology|December 4, 2013
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trialSung Won Choi, Thomas Braun, Lawrence Chang, et al.
Pageof 4